Hi Ryan,
I like your post..You seem to be a very honest and determined investor and take what you read on these boards with great interest.
You are right..You have your posters with egos and think they know it all, but allow me to elaborate.
Myself, I am a professional trader and do this for a living and I also profile companies for a fee..However, I don't think, many like myself, come to these threads to educate newbie's, but rather exchange information and discuss the particular filings and such.
I see ihub as a tool for investment on issues that others may have done considerable more DD..Remember, there are thousands of companies on the various exchanges and message boards are a great place to disseminate info from the good and the bad on a split moment...Most veteran traders view these venues as such.
Many traders don't have the time or desire to fully involve themselves to dig deep into a particular company that may have sparked their interest and on that note, could care less on the fundamentals of such company....Thus they come to these boards and yes, they challenge people, but with the intent to fully bring any agenda that may be adverse or positive to the surface.
It is in this vain that some and in the case, of this thread, GNTA, where much of the hostiles have become so rabid..
GNTA has been around for a long time and I go way back with GNTA, but on that note, they do have a serious problem with funding and it is solely relied on Equity type financial instrument and share holders to continue.
No, I don't expect GNTA to go BK, but, and this is something that most here feel not to understand...Current shareholders, just like the ones from last year or going back 10 years have not benefited by holding long..If a shareholder from 10 years ago still held today, would've have seen his/her investment dwindle down to nothing today..
These message boards and the posters from all walks of life have different agendas and not one will have the courage to say that this issue is very speculative to say the least..
Will they get approved on their drugs??That still remains a question mark and not one poster here or anywhere else can say otherwise..This issue is a very risky play and requires patience.
The company will do a R/S and the only question now is what ratio..The CC was not meant to give any indication on anything other than what the company's plan is that hasn't been already been known in the public domain..
There was much hype on the CC and was falsely mentioned on this forum that news would be huge..CC are not venues for NEW news...
Much of the trading on this issue is manipulation coming from the German exchange and the shorts from the offshore that have a direct contact with certain market makers..However, most importantly, the company is diluting the pool that is certainly uncommon, but expected, since a R/S is pending...This is a sad point and very disappointing.
Will the drugs survive and work there way through clinical trials?? This is still in the works and yes, they have setbacks, but ROI for shareholders and most importantly for current shareholders remains a question mark.. This is still uncertain as the previous shareholder of the last 20 years have still not realized their ROI.
Gnta is a speculative issue and not one poster or interested investor can argue otherwise..
Currently this issue is a very predictable trading stock and the day-traders will continue to make money on whatever it brings tomorrow..
The wild swings are in the foreseeable future..Of course until the R/S that is pending in July and then it's a new day..
This is the nature of a Bio-Tech in R&D.
Have a good day
Varok
News 
Market Data 
Discover 
AI
